Startup ClostraBio aims to cure food allergies. 

“ClostraBio … is developing therapeutics which boost this protective microbial barrier function in individuals where it has been compromised. The startup is working to develop a pill in order to administer its treatment, and currently testing for peanut allergies, with potential applications towards other allergens and protection from diseases linked to food allergies, such as eczema, asthma, and inflammatory bowel disease (IBD).” | learn more